Showing results (91-100 of 132) with videos related to
Sort By:
Pageof 14
Anticancer Research|December 8, 2020
Significance of Pre-treatment Interferon-gamma Release in Patients With Non-small-cell Lung Cancer Receiving Immune Checkpoint InhibitorsTomonori Hirashima, Tomohiro Kanai, Hidekazu Suzuki, et al.Journal of Thoracic Disease|April 10, 2019
Re-challenge chemotherapy in patients with sensitive relapse small-cell lung cancer and interstitial lung diseaseShingo Nasu, Hidekazu Suzuki, Kazunori Moriizumi, et al.BMC Pulmonary Medicine|May 13, 2016
Radial endobronchial ultrasound with a guide sheath for diagnosis of peripheral cavitary lung lesions: a retrospective studyManabu Hayama, Norio Okamoto, Hidekazu Suzuki, et al.Molecular and Clinical Oncology|March 21, 2014
Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseasesHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.Scientific Reports|September 4, 2020
Liver dysfunction is associated with poor prognosis in patients after immune checkpoint inhibitor therapyKeisuke Yokohama, Akira Asai, Masahiro Matsui, et al.Anticancer Research|October 2, 2019
Comparison of the Utilities of Cryobiopsy and Forceps Biopsy for Peripheral Lung CancerShingo Nasu, Norio Okamoto, Hidekazu Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 23, 2015
[Evaluation of the Safety of a Generic Formulation of Cisplatin in Patients with Thoracic Malignancies]Yuki Ueda, Yoko Kondo, Hidekazu Suzuki, et al.Thorax|November 17, 2025
Balloon dilatation for bronchoscope delivery: first-in-human trial of a novel technique for peripheral lung field accessKotaro Miyake, Masahide Oki, Hidekazu Suzuki, et al.Anticancer Research|August 1, 2018
Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung CancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.Cancer Medicine|November 19, 2017
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.Pageof 14